Ergoteles’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Ergoteles’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-325	Closed	-$149K	–	1446
2021 Q3	$149K	Sell	325 -295	-48%	-$112K	0.01%	1053
2021 Q2	$249K	Buy	+620	New	+$282K	0.01%	1167

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ergoteles's LYRA Position: Q4 2021 in Review

Ergoteles sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2021, closing a stake of 325 shares — an estimated $149K sold.

Ergoteles first reported a position in LYRA in Q2 2021 and held it in 2 quarters. The position peaked at $249K in Q2 2021. 33 funds tracked by Wall St. Rank hold LYRA as of Q4 2021.

Ergoteles reported no remaining LYRA THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 325 LYRA THERAPEUTICS INC shares in Q4 2021, an estimated $149K.
Ergoteles first reported a position in LYRA THERAPEUTICS INC in Q2 2021 and held it in 2 quarters.
Ergoteles's LYRA THERAPEUTICS INC position peaked at $249K in Q2 2021.
33 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.